NO20023977L - 8,8A-dihydro-indeno(1,2-D)tiazolderivater med en sulfonamid- eller sulfonsubstituent i 2-posisjonen, deres fremstilling oganvendelse - Google Patents

8,8A-dihydro-indeno(1,2-D)tiazolderivater med en sulfonamid- eller sulfonsubstituent i 2-posisjonen, deres fremstilling oganvendelse

Info

Publication number
NO20023977L
NO20023977L NO20023977A NO20023977A NO20023977L NO 20023977 L NO20023977 L NO 20023977L NO 20023977 A NO20023977 A NO 20023977A NO 20023977 A NO20023977 A NO 20023977A NO 20023977 L NO20023977 L NO 20023977L
Authority
NO
Norway
Prior art keywords
preparation
sulfonamide
dihydroindo
thiazole derivatives
sulfone substituent
Prior art date
Application number
NO20023977A
Other languages
English (en)
Other versions
NO323400B1 (no
NO20023977D0 (no
Inventor
Gerhard Jaehne
Hans-Jochen Lang
Matthias Gossel
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20023977D0 publication Critical patent/NO20023977D0/no
Publication of NO20023977L publication Critical patent/NO20023977L/no
Publication of NO323400B1 publication Critical patent/NO323400B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Indole Compounds (AREA)
NO20023977A 2000-02-26 2002-08-21 Polycykliske dihydrotiazol-forbindelser og farmasoytiske preparater inneholdende slike, deres fremstilling og anvendelse for profylakse eller behandling av fedme og type II diabetes. NO323400B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10009311 2000-02-26
PCT/EP2001/001553 WO2001062747A1 (de) 2000-02-26 2001-02-13 8,8a-dihydro-indeno[1,2-d]thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO20023977D0 NO20023977D0 (no) 2002-08-21
NO20023977L true NO20023977L (no) 2002-10-18
NO323400B1 NO323400B1 (no) 2007-04-23

Family

ID=7632679

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023977A NO323400B1 (no) 2000-02-26 2002-08-21 Polycykliske dihydrotiazol-forbindelser og farmasoytiske preparater inneholdende slike, deres fremstilling og anvendelse for profylakse eller behandling av fedme og type II diabetes.

Country Status (29)

Country Link
US (2) US6352987B2 (no)
EP (1) EP1261593B1 (no)
JP (1) JP4950405B2 (no)
KR (1) KR100763214B1 (no)
CN (1) CN1173959C (no)
AT (1) ATE248155T1 (no)
AU (2) AU4413601A (no)
BR (1) BR0108631A (no)
CA (1) CA2400704C (no)
CZ (1) CZ301253B6 (no)
DE (1) DE50100558D1 (no)
DK (1) DK1261593T3 (no)
EE (1) EE04963B1 (no)
ES (1) ES2206412T3 (no)
HK (1) HK1052515B (no)
HR (1) HRP20020687B1 (no)
HU (1) HU229137B1 (no)
IL (1) IL151460A (no)
MX (1) MXPA02007025A (no)
NO (1) NO323400B1 (no)
NZ (1) NZ520981A (no)
PL (1) PL202763B1 (no)
PT (1) PT1261593E (no)
RS (1) RS49933B (no)
RU (1) RU2263113C2 (no)
SI (1) SI1261593T1 (no)
SK (1) SK285571B6 (no)
WO (1) WO2001062747A1 (no)
ZA (1) ZA200206580B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7261482B2 (en) * 2004-01-21 2007-08-28 Silverbrook Research Pty Ltd Photofinishing system with slitting mechanism
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
JP5557845B2 (ja) 2008-10-31 2014-07-23 メルク・シャープ・アンド・ドーム・コーポレーション 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
AU2011218830B2 (en) 2010-02-25 2014-07-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX348131B (es) 2011-02-25 2017-05-26 Merck Sharp & Dohme Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos.
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
WO2014022528A1 (en) 2012-08-02 2014-02-06 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
WO2014130608A1 (en) 2013-02-22 2014-08-28 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
WO2014139388A1 (en) 2013-03-14 2014-09-18 Merck Sharp & Dohme Corp. Novel indole derivatives useful as anti-diabetic agents
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
WO2015051496A1 (en) 2013-10-08 2015-04-16 Merck Sharp & Dohme Corp. Antidiabetic tricyclic compounds
US11072602B2 (en) 2016-12-06 2021-07-27 Merck Sharp & Dohme Corp. Antidiabetic heterocyclic compounds
EP3558298B1 (en) 2016-12-20 2026-03-11 Merck Sharp & Dohme LLC Antidiabetic spirochroman compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
CZ2001170A3 (cs) * 1999-07-03 2001-06-13 Aventis Pharma Gmbh Polycyklické thiazolidin-2-ylidenaminy, způsob jejich přípravy a léčivo, které je obsahuje
CZ20011111A3 (cs) * 1999-09-16 2001-07-11 Aventis Pharma Deutschland Gmbh Deriváty indeno-, nafto- a benzocyklohepťadihydrothiazolu, jejich příprava a použití jako anorektická léčiva

Also Published As

Publication number Publication date
US20020103231A1 (en) 2002-08-01
CN1406234A (zh) 2003-03-26
AU4413601A (en) 2001-09-03
IL151460A (en) 2008-08-07
YU56402A (sh) 2005-11-28
EE200200467A (et) 2003-12-15
RU2263113C2 (ru) 2005-10-27
MXPA02007025A (es) 2003-03-27
HRP20020687B1 (hr) 2011-01-31
PL202763B1 (pl) 2009-07-31
HUP0300304A2 (hu) 2003-06-28
CZ20022861A3 (cs) 2002-11-13
NO323400B1 (no) 2007-04-23
DE50100558D1 (de) 2003-10-02
SK12252002A3 (sk) 2003-03-04
JP2003531117A (ja) 2003-10-21
CN1173959C (zh) 2004-11-03
US6444669B1 (en) 2002-09-03
EP1261593A1 (de) 2002-12-04
NZ520981A (en) 2004-08-27
CA2400704A1 (en) 2001-08-30
EE04963B1 (et) 2008-02-15
SK285571B6 (sk) 2007-04-05
DK1261593T3 (da) 2003-12-01
SI1261593T1 (en) 2004-02-29
US20010039278A1 (en) 2001-11-08
RS49933B (sr) 2008-09-29
EP1261593B1 (de) 2003-08-27
RU2002125673A (ru) 2004-01-10
BR0108631A (pt) 2002-12-03
CA2400704C (en) 2008-11-04
HUP0300304A3 (en) 2004-10-28
CZ301253B6 (cs) 2009-12-23
ZA200206580B (en) 2003-05-15
HRP20020687A2 (en) 2004-12-31
WO2001062747A1 (de) 2001-08-30
ATE248155T1 (de) 2003-09-15
KR100763214B1 (ko) 2007-10-08
ES2206412T3 (es) 2004-05-16
JP4950405B2 (ja) 2012-06-13
PL357195A1 (en) 2004-07-26
HK1052515B (zh) 2005-04-22
NO20023977D0 (no) 2002-08-21
PT1261593E (pt) 2004-01-30
HK1052515A1 (en) 2003-09-19
HU229137B1 (en) 2013-08-28
AU2001244136B2 (en) 2005-04-14
US6352987B2 (en) 2002-03-05
KR20020079897A (ko) 2002-10-19

Similar Documents

Publication Publication Date Title
DK1261593T3 (da) 8,8a-Dihydro-indeno[1,2-d]thiazol-derivater med en sulfonamido- eller sulfonosubstituent i 2-stillingen, en fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
NO20023978L (no) 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
BR0208192A (pt) Derivados espirotricìclicos e seu uso como inibidores da fosfodiesterase-7.
NO20072689L (no) Tetrasykliske indolderivater som antivirale midler
BRPI0209216B8 (pt) derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos
MY138352A (en) Benzothiazole derivatives
BR0310057A (pt) melhoria do desenvolvimento de catarata e outras doenças oftálmicas
DE60121461D1 (de) Kondensierte pyridoindolderivate
GT200000103A (es) Trifluorbutenos nematocidas.
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20062491L (no) Benzoksazinderivter og deres anvendelse
EP1671957A4 (en) THIADIAZOLINDERIVATE
EA200970497A1 (ru) Производные пиррола, их получение и их применение в терапии
MA27077A1 (fr) Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible
DE50010403D1 (de) Polycyclische thiazol-systeme und ihre verwendung als anorektika
BR0214488A (pt) Derivados de benzotiazol
BR0016937A (pt) Compostos tricìclicos e método de tratar herpesvìrus
ATE452876T1 (de) Aminoalkoholderivate
NO20053876L (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav
NO20023955D0 (no) Substituerte 8,8a-dihydro-3aH-indeno[1,2-d]tiazoler, en fremgangsmåte for fremstilling og deres anvendelse sommedikamenter
UY26347A1 (es) Derivados de bencimidazol sustituidos con arilsulfonamida, procedimiento para su preparación y su empleo como medicamentos.
UY26346A1 (es) Derivados de bencimidazol sustituidos, procedimiento para preparación y su empleo como medicamentos.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees